Recommended Topic Related To:

Neupro

"Nov. 6, 2012 -- Exercise helps put people with Parkinson's disease on a path to better health, a new study shows.

All Parkinson's patients reach a point in their disease where they begin to have trouble walking. Typically, a person st"...

Neupro

font size
Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

Neupro
(rotigotine transdermal system)

DRUG DESCRIPTION

Neupro is a transdermal system that provides continuous delivery of rotigotine, a non-ergoline dopamine agonist, for 24 hours following application to intact skin.

Neupro is available in six strengths as shown in Table 4.

Table 4 : Nominal Dose, Drug Content, and Transdermal System Size

Neupro Nominal Dose Rotigotine Content per System Neupro System Size
1 mg/24 hours 2.25 mg 5 cm²
2 mg/24 hours 4.5 mg 10 cm²
3 mg/24 hours 6.75 mg 15 cm²
4 mg/24 hours 9 mg 20 cm²
6 mg/24 hours 13.5 mg 30 cm²
8 mg/24 hours 18 mg 40 cm²

The chemical name of rotigotine is (6S)-6-{propyl[2-(2-thienyl)ethyl]amino}-5,6,7,8-tetrahydro-1-naphthalenol. The empirical formula is C19H25NOS. The molecular weight is 315.48. The structural formula for rotigotine is:.

Neupro (Rotigotine) Structural Formula Illustration

System Components and Structure

Neupro is a thin, matrix-type transdermal system composed of three layers as shown in Figure 1:

Figure 1: System Schematic

System Schematic - Illustration

A flexible, tan-colored backing film, consisting of an aluminized polyester film coated with a pigment-layer on the outer side. The backing provides structural support and protection of the drug-loaded adhesive layer from the environment.

A self-adhesive drug matrix layer, consisting of the active component rotigotine and the following inactive components: ascorbyl palmitate, povidone, silicone adhesive, sodium metabisulfite, and dl-alpha-tocopherol.

A protective liner, consisting of a transparent fluoropolymer-coated polyester film. This liner protects the adhesive layer during storage and is removed just prior to application.

Last reviewed on RxList: 4/13/2012
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.

Please acknowledge your agreement
advertisement
advertisement
Use Pill Finder Find it Now

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies
Search the Medical Dictionary for Health Definitions & Medical Abbreviations